BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Akari Therapeutics to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

  May 22, 2025

   · 

  2 min read
• Press Releases

  ulrich medical USA® Appoints Eric Gibbs as President and General Manager

  May 22, 2025

   · 

  2 min read
• Press Releases

  Scribe Therapeutics Reports Positive Preclinical Data on its Novel CRISPR Technologies at the 2025 EAS Congress and ASGCT Annual Meeting

  May 22, 2025

   · 

  5 min read
• Press Releases

  Avenzo Therapeutics Announces FDA Clearance of Investigational New Drug Application for AVZO-1418, a Potential Best-in-Class, Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate

  May 22, 2025

   · 

  2 min read
• 

  Job Trends

  Exit Strategy: Biopharma Pros Look Outside Industry—and US

  A BioSpace survey found that 56% of employed and 81% of unemployed respondents are considering jobs outside biopharma. Some are also seriously thinking about leaving the U.S. to find employment in the field.

  May 22, 2025

   · 

  6 min read

   · 

  Angela Gabriel
• Press Releases

  New Research Exposes Why Biotech’s Best Scientists Can’t Tell Companies Apart - And Reveals the Zero-Budget Fix That’s Already Working

  First-Ever Industry Analysis Shows 83% Message Overlap Forcing Biotechs Into Costly Talent Bidding Wars

  May 22, 2025

   · 

  1 min read
• Press Releases

  Bayer Launches Centafore Imaging Core Lab to Support Imaging for Clinical Trials and Software as a Medical Device Development

  May 22, 2025

   · 

  5 min read
• Press Releases

  Medicus Pharma Ltd Receives Study May Proceed Approval from United Arab Emirates (UAE) Department of Health (DOH) to Commence Phase 2 Clinical Study (SKNJCT-004) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

  The Clinical Study Is Expected to Randomize 36 Participants in Cleveland Clinic Abu Dhabi (CCAD) and Three Other Clinical Sites in UAE

  May 22, 2025

   · 

  7 min read
• Press Releases

  PreveCeutical Closes Final Tranche of Up-Sized Non-Brokered Private Placement

  May 22, 2025

   · 

  5 min read
• Press Releases

  Sharp Therapeutics Corp. Reports First Quarter 2025 Results

  May 22, 2025

   · 

  3 min read